Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus

Diabetic Retinopathy (DR) is the leading cause of vision loss in adults aged 20–74 years. DR classified as the fifth most common cause of preventable blindness and fifth furthermost common cause of moderate to severe visual impairment. A retrospective cohort study was performed to evaluate the preva...

Full description

Bibliographic Details
Main Authors: Hammad, Mohamed Anwar, Mohamed Noor, Dzul Azri, Syed Sulaiman, Syed Azhar, Elsayed, Tarek Mohamed Ali
Format: Article
Language:English
Published: Science Publishing Group 2017
Subjects:
Online Access:http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/1/10.11648.j.ijovs.20170204.15.pdf
id iium-58625
recordtype eprints
spelling iium-586252018-01-12T07:55:39Z http://irep.iium.edu.my/58625/ Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus Hammad, Mohamed Anwar Mohamed Noor, Dzul Azri Syed Sulaiman, Syed Azhar Elsayed, Tarek Mohamed Ali RE Ophthalmology RS Pharmacy and materia medica Diabetic Retinopathy (DR) is the leading cause of vision loss in adults aged 20–74 years. DR classified as the fifth most common cause of preventable blindness and fifth furthermost common cause of moderate to severe visual impairment. A retrospective cohort study was performed to evaluate the prevalence of DR, and the effect of statins on the DR, among outpatients with Type 2 diabetes mellitus. The study was done at the endocrine clinic in Hospital Pulau Pinang, Malaysia. Two cohorts of 717 diabetic outpatients (559 statins user and 158 statins non-users) were investigated for demographic data and diagnosis of DR. Findings were presented as descriptive statistics. The age of 717 subjects was (55.2±14.9) years and females 367 (51.2%). About 166 (23.2%) patients had DR with age (58.2±14.9) years. From 559 (78%) outpatients were statins-user, 143 (25.6%) had DR with age (58.5±14.9) years. While the control group 158 (22%) participants, only 23 (14.6%) had DR with age (56.3±14.9) years. The relative risk (RR) for DR in the statin-user group for DR is 1.75 and excessive relative risk (ERR) 75%. The absolute risk (AR) is 11% and number need to harm (NNH) is 9. Nearly one-quarter of the subjects had diabetic retinopathy. The risk of diabetic retinopathy incidence is higher in the statins user group than statins non-user cohort. Science Publishing Group 2017 Article PeerReviewed application/pdf en http://irep.iium.edu.my/58625/1/10.11648.j.ijovs.20170204.15.pdf Hammad, Mohamed Anwar and Mohamed Noor, Dzul Azri and Syed Sulaiman, Syed Azhar and Elsayed, Tarek Mohamed Ali (2017) Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus. International Journal of Ophthalmology & Visual Science, 2 (4). pp. 106-114. http://article.sciencepublishinggroup.com/pdf/10.11648.j.ijovs.20170204.15.pdf 10.11648/j.ijovs.20170204.15
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic RE Ophthalmology
RS Pharmacy and materia medica
spellingShingle RE Ophthalmology
RS Pharmacy and materia medica
Hammad, Mohamed Anwar
Mohamed Noor, Dzul Azri
Syed Sulaiman, Syed Azhar
Elsayed, Tarek Mohamed Ali
Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
description Diabetic Retinopathy (DR) is the leading cause of vision loss in adults aged 20–74 years. DR classified as the fifth most common cause of preventable blindness and fifth furthermost common cause of moderate to severe visual impairment. A retrospective cohort study was performed to evaluate the prevalence of DR, and the effect of statins on the DR, among outpatients with Type 2 diabetes mellitus. The study was done at the endocrine clinic in Hospital Pulau Pinang, Malaysia. Two cohorts of 717 diabetic outpatients (559 statins user and 158 statins non-users) were investigated for demographic data and diagnosis of DR. Findings were presented as descriptive statistics. The age of 717 subjects was (55.2±14.9) years and females 367 (51.2%). About 166 (23.2%) patients had DR with age (58.2±14.9) years. From 559 (78%) outpatients were statins-user, 143 (25.6%) had DR with age (58.5±14.9) years. While the control group 158 (22%) participants, only 23 (14.6%) had DR with age (56.3±14.9) years. The relative risk (RR) for DR in the statin-user group for DR is 1.75 and excessive relative risk (ERR) 75%. The absolute risk (AR) is 11% and number need to harm (NNH) is 9. Nearly one-quarter of the subjects had diabetic retinopathy. The risk of diabetic retinopathy incidence is higher in the statins user group than statins non-user cohort.
format Article
author Hammad, Mohamed Anwar
Mohamed Noor, Dzul Azri
Syed Sulaiman, Syed Azhar
Elsayed, Tarek Mohamed Ali
author_facet Hammad, Mohamed Anwar
Mohamed Noor, Dzul Azri
Syed Sulaiman, Syed Azhar
Elsayed, Tarek Mohamed Ali
author_sort Hammad, Mohamed Anwar
title Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
title_short Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
title_full Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
title_fullStr Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
title_full_unstemmed Statins effects on diabetic retinopathy among patients with Type 2 Diabetes Mellitus
title_sort statins effects on diabetic retinopathy among patients with type 2 diabetes mellitus
publisher Science Publishing Group
publishDate 2017
url http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/
http://irep.iium.edu.my/58625/1/10.11648.j.ijovs.20170204.15.pdf
first_indexed 2023-09-18T21:22:56Z
last_indexed 2023-09-18T21:22:56Z
_version_ 1777412002568732672